- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Medicamen Biotech Limited — Important, 07-01-2026: Updates
07-01-2026 | 04:06 pm
07-01-2026 | 04:06 pm
Medicamen Biotech received EU approval for Paracetamol product registration from the Danish Medicine Authority, in partnership with XGX Pharma. This is a positive business development, potentially opening new market opportunities in Europe.
No comments yet. Be the first to comment!